Rob Goodwin currently serves as Chief Operating Officer at Parexel, leading core clinical functions and ensuring high quality and compliance in clinical trial data processes. Previously, Rob held various senior positions at Pfizer from 1998 to 2025, most notably as Senior Vice President of Clinical Development and Operations, where responsibilities included overseeing clinical trials globally and managing operational capabilities. Additional roles at Pfizer encompassed Vice President positions focused on operational excellence, safety evaluation, and pharmacovigilance operations. Rob holds an MBA in Pharmaceutical and Chemical Studies from Fairleigh Dickinson University and a BS in Psychology and Business from Eastern Connecticut State University.
This person is not in any teams
This person is not in any offices